JP2025511000A5 - - Google Patents

Info

Publication number
JP2025511000A5
JP2025511000A5 JP2024557573A JP2024557573A JP2025511000A5 JP 2025511000 A5 JP2025511000 A5 JP 2025511000A5 JP 2024557573 A JP2024557573 A JP 2024557573A JP 2024557573 A JP2024557573 A JP 2024557573A JP 2025511000 A5 JP2025511000 A5 JP 2025511000A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
acid sequence
antigen
binding molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024557573A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025511000A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2023/057751 external-priority patent/WO2023186756A1/en
Publication of JP2025511000A publication Critical patent/JP2025511000A/ja
Publication of JP2025511000A5 publication Critical patent/JP2025511000A5/ja
Pending legal-status Critical Current

Links

JP2024557573A 2022-03-28 2023-03-27 インターフェロンガンマバリアントおよびこれを含む抗原結合分子 Pending JP2025511000A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP22164773 2022-03-28
EP22164773.8 2022-03-28
PCT/EP2023/057751 WO2023186756A1 (en) 2022-03-28 2023-03-27 Interferon gamma variants and antigen binding molecules comprising these

Publications (2)

Publication Number Publication Date
JP2025511000A JP2025511000A (ja) 2025-04-15
JP2025511000A5 true JP2025511000A5 (cg-RX-API-DMAC7.html) 2026-04-02

Family

ID=80978821

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024557573A Pending JP2025511000A (ja) 2022-03-28 2023-03-27 インターフェロンガンマバリアントおよびこれを含む抗原結合分子

Country Status (5)

Country Link
US (1) US20250333542A1 (cg-RX-API-DMAC7.html)
EP (1) EP4499229A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025511000A (cg-RX-API-DMAC7.html)
CN (1) CN119095880A (cg-RX-API-DMAC7.html)
WO (1) WO2023186756A1 (cg-RX-API-DMAC7.html)

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL85035A0 (en) 1987-01-08 1988-06-30 Int Genetic Eng Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
JP3101690B2 (ja) 1987-03-18 2000-10-23 エス・ビィ・2・インコーポレイテッド 変性抗体の、または変性抗体に関する改良
FI903489A7 (fi) 1988-11-11 1990-07-10 Medical Res Council Yhden osan sisältävät ligandit, näitä ligandeja sisältävät reseptorit, menetelmiä niiden valmistamiseksi sekä ligandien ja reseptorien käytt ö
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
US5959177A (en) 1989-10-27 1999-09-28 The Scripps Research Institute Transgenic plants expressing assembled secretory antibodies
US5571894A (en) 1991-02-05 1996-11-05 Ciba-Geigy Corporation Recombinant antibodies specific for a growth factor receptor
EP0590058B1 (en) 1991-06-14 2003-11-26 Genentech, Inc. HUMANIZED Heregulin ANTIBODy
GB9114948D0 (en) 1991-07-11 1991-08-28 Pfizer Ltd Process for preparing sertraline intermediates
FI941572L (fi) 1991-10-07 1994-05-27 Oncologix Inc Anti-erbB-2-monoklonaalisten vasta-aineiden yhdistelmä ja käyttömenetelmä
CA2372813A1 (en) 1992-02-06 1993-08-19 L.L. Houston Biosynthetic binding protein for cancer marker
AU691811B2 (en) 1993-06-16 1998-05-28 Celltech Therapeutics Limited Antibodies
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
US5869046A (en) 1995-04-14 1999-02-09 Genentech, Inc. Altered polypeptides with increased half-life
GB9603256D0 (en) 1996-02-16 1996-04-17 Wellcome Found Antibodies
JP2002506353A (ja) 1997-06-24 2002-02-26 ジェネンテック・インコーポレーテッド ガラクトシル化糖タンパク質の方法及び組成物
US6040498A (en) 1998-08-11 2000-03-21 North Caroline State University Genetically engineered duckweed
DE19742706B4 (de) 1997-09-26 2013-07-25 Pieris Proteolab Ag Lipocalinmuteine
CA2307166A1 (en) 1997-10-31 1999-05-14 Genentech, Inc. Methods and compositions comprising glycoprotein glycoforms
AUPP221098A0 (en) 1998-03-06 1998-04-02 Diatech Pty Ltd V-like domain binding molecules
JP4334141B2 (ja) 1998-04-20 2009-09-30 グリカート バイオテクノロジー アクチェンゲゼルシャフト 抗体依存性細胞傷害性を改善するための抗体のグリコシル化操作
WO2000032634A1 (en) 1998-12-01 2000-06-08 Protein Design Labs, Inc. Humanized antibodies to gamma-interferon
US6818418B1 (en) 1998-12-10 2004-11-16 Compound Therapeutics, Inc. Protein scaffolds for antibody mimics and other binding proteins
US7115396B2 (en) 1998-12-10 2006-10-03 Compound Therapeutics, Inc. Protein scaffolds for antibody mimics and other binding proteins
US6737056B1 (en) 1999-01-15 2004-05-18 Genentech, Inc. Polypeptide variants with altered effector function
HUP0104865A3 (en) 1999-01-15 2004-07-28 Genentech Inc Polypeptide variants with altered effector function
CA2378403A1 (en) 1999-07-26 2001-02-01 Genentech, Inc. Novel polynucleotides and method for the use thereof
KR100797667B1 (ko) 1999-10-04 2008-01-23 메디카고 인코포레이티드 외래 유전자의 전사를 조절하는 방법
US7125978B1 (en) 1999-10-04 2006-10-24 Medicago Inc. Promoter for regulating expression of foreign genes
EP1332209B1 (en) 2000-09-08 2009-11-11 Universität Zürich Collections of repeat proteins comprising repeat modules
EP1423510A4 (en) 2001-08-03 2005-06-01 Glycart Biotechnology Ag ANTIBODY GLYCOSYLATION VARIANTS WITH INCREASED ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY
PL213948B1 (pl) 2001-10-25 2013-05-31 Genentech Inc Kompozycje zawierajace glikoproteine, czasteczka kwasu nukleinowego kodujaca te glikoproteine, komórka gospodarza, sposób wytwarzania glikoproteiny, kompozycja do zastosowania do leczenia, zastosowanie kompozycji i zestaw zawierajacy kompozycje
US20040093621A1 (en) 2001-12-25 2004-05-13 Kyowa Hakko Kogyo Co., Ltd Antibody composition which specifically binds to CD20
US7361740B2 (en) 2002-10-15 2008-04-22 Pdl Biopharma, Inc. Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis
HUE035898T2 (en) 2002-12-16 2018-05-28 Genentech Inc Immunoglobulin variants and their applications
CA2531238C (en) 2003-07-04 2015-02-24 Affibody Ab Polypeptides having binding affinity for her2
WO2005019255A1 (en) 2003-08-25 2005-03-03 Pieris Proteolab Ag Muteins of tear lipocalin
HUE038955T2 (hu) 2003-11-05 2018-12-28 Roche Glycart Ag Antigén-kötõ molekulák fokozott Fc receptor-kötõ affinitással és effektor funkcióval
BRPI0417302A (pt) 2003-12-05 2007-03-06 Compound Therapeutics Inc inibidores de receptores de fator de crescimento endotelial vascular do tipo 2
TR201808537T4 (tr) 2004-09-23 2018-07-23 Genentech Inc Sistein değiştirilmiş antikorlar ve konjugatlar.
DE102007001370A1 (de) 2007-01-09 2008-07-10 Curevac Gmbh RNA-kodierte Antikörper
EP1958957A1 (en) 2007-02-16 2008-08-20 NascaCell Technologies AG Polypeptide comprising a knottin protein moiety
PE20171512A1 (es) 2010-08-13 2017-10-20 Roche Glycart Ag Anticuerpos anti-fap
LT2691417T (lt) 2011-03-29 2018-10-25 Roche Glycart Ag Antikūno fc variantai
US20180057603A1 (en) 2013-08-09 2018-03-01 The Trustees Of The University Of Pennsylvania Combination of IFN-gamma with Anti-ERBB Antibody for the Treatment of Cancers
ES2774380T3 (es) 2014-08-29 2020-07-20 Hoffmann La Roche Politerapia de inmunocitocinas de variante de IL-2 dirigida a tumor y anticuerpos frente a PD-L1 humano
EP3243836A1 (en) * 2016-05-11 2017-11-15 F. Hoffmann-La Roche AG C-terminally fused tnf family ligand trimer-containing antigen binding molecules
CN111246884A (zh) * 2017-11-01 2020-06-05 豪夫迈·罗氏有限公司 新颖的含有tnf家族配体三聚体的抗原结合分子
WO2022207521A1 (en) * 2021-03-30 2022-10-06 F. Hoffmann-La Roche Ag Protease-activated polypeptides

Similar Documents

Publication Publication Date Title
ES2439802T3 (es) Anticuerpos tri- o tetraespecíficos
JP2023178323A5 (cg-RX-API-DMAC7.html)
CN103068846B9 (zh) 包含二硫键稳定性Fv片段的双特异性抗体
IL272747B1 (en) Bispecific antibodies 1 + 2
JP2025160226A5 (cg-RX-API-DMAC7.html)
TW202227491A (zh) 抗ror1抗體及相關雙特異性結合蛋白
IL292780A (en) A new 4-1bbl trimer containing antigen-binding molecules
JP2023511376A5 (cg-RX-API-DMAC7.html)
US20230192887A1 (en) Engineered anti-her2 bispecific proteins
TW201111394A (en) Bispecific, tetravalent antigen binding proteins
AU2005214988A1 (en) Super-humanized antibodies against respiratory syncytial virus
JP2024532489A5 (cg-RX-API-DMAC7.html)
JP2022538222A5 (cg-RX-API-DMAC7.html)
JP2023531494A5 (cg-RX-API-DMAC7.html)
TW201113037A (en) Antibodies against CDCP1 for the treatment of cancer
CN1381461A (zh) 抗人肝癌单克隆抗体HAb18轻、重链可变区基因及其应用
JP2022521305A (ja) 抗pd-l1抗体及びその使用
JPWO2022224997A5 (cg-RX-API-DMAC7.html)
WO2025041097A1 (en) Il-18 polypeptides fused to immune cell antigen specific binding polypeptides and uses thereof
EP4559932A1 (en) Multispecific antibody and use thereof
US20260109781A1 (en) Anti-her2 antibodies and methods of use thereof
CN112500491B (zh) 一种特异性中和辅助性T细胞TGF-β信号的双特异性抗体、其药物组合及其用途
WO2024061224A1 (zh) 抗her2抗体及其用途
JP2024504931A5 (cg-RX-API-DMAC7.html)
US20240392035A1 (en) Engineered anti-her2 bispecific proteins